Mercks Capvaxive is formulated to cover pneumococcal strains responsible for approximately 84% of invasive pneumococcal disease
Exenatide delays gastric emptying in patients with Type 2 diabetes mellitus but not in those with gastroparetic conditions
SAS v9.4 (TS1M5) pharmacokinetic software was used to calculate pharmacokinetic values
Guo D, Han B, Lu Y, Lv C, Fang X, Zhang Z, et al
Participants receiving higher doses of the drug were more likely to experience mild-moderate GI issues, such as nausea, vomiting, diarrhoea, and constipation
You should not change your dosing regimen or stop taking Zepbound as prescribed without discussing with your provider first